Episode Details
Back to Episodes
Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 3
Season 26
Episode 327
Published 1 week, 5 days ago
Description
Featuring perspectives from Prof John Seymour, including the following topics:
- Safety of fixed-duration acalabrutinib/venetoclax for chronic lymphocytic leukemia (CLL) (0:00)
- Venetoclax re-treatment and ongoing trials with acalabrutinib/venetoclax for CLL (6:21)
- First-line treatment with sonrotoclax and zanubrutinib for CLL (13:10)